Spanance is bringing its future site and development concept to life for CPHI Milan 2026, featuring an immersive virtual tour.
Published
Signal category
Products & Services
Quote
“As we prepare for CPHI Milan 2026, we are bringing our future site and development concept to life.”
— Spanance team
Company
Spanance
Aseptic Fill-Finish | Advancing Science, Enhancing Life
- Industry
- Pharmaceutical Manufacturing
- Company size
- 3 employees
Spanance is a next-generation aseptic fill-finish CDMO built for optionality. From our 3,000 m² GMP-designed site in Mação, Portugal, we are developing flexible manufacturing capacity for sterile injectable programs from clinical batches through commercial scale. Our modular architecture, independent HVAC and isolator-based technology are designed to support multiple formats, batch sizes and partner needs, including vials, pre-filled syringes and cartridges. We work with pharma and biotech companies seeking agile European fill-finish capacity, technology transfer and strategic manufacturing partnerships.